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Outline
• Defining the challenge
• History of Spaceflight Medical Systems
• Mars is different
• Principles of Approach
• Scoping a Medical System
• Where are we now?
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What is the challenge?
• When we say “Mission to Mars" what do we really 
mean?
• What implications does that have for how you provide 
medical care?
• Is this really so different from what we do on the ISS 
or when we went to the moon?
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ExMC Responsibilities
Risk Title: Risk of Adverse Health Outcomes & Decrements 
in Performance due to Inflight Medical Conditions 
Description: Given that medical conditions will occur during 
human spaceflight missions, there is a possibility of adverse 
health outcomes and decrements in performance during these 
missions and for long term health.
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Our Mission
To minimize mission medical risk through medical system 






NASA, because of its mission and history, has 
tended to be an insular organization 
dominated by traditional engineering.  
Because of the engineering problems 
associated with early space endeavors, the 
historical approach to solving problems has 
been that of engineering.  Long duration 
space travel will require a different approach, 
one requiring wider participation of those with 
expertise in divergent, emerging, and evolving 
fields.  NASA has only recently begun to 
recognize this insufficiency and to reach out 
to communities, both domestic and 
international, to gain expertise on how to 




Principles of Clinical Medicine for Spaceflight
Eds. Barratt, Pool, 2008
Gemini and Apollo
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Principles of Clinical Medicine for Spaceflight
Eds. Barratt, Pool, 2008
Space Shuttle
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Principles of Clinical Medicine for Spaceflight
Eds. Barratt, Pool, 2008





Start of a medical-vehicle system

















Trans-Mars Cruise About 9 months
Going there
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Wait on Mars About 16 months
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Being there




Mars at return Earth at return
Spacecraft at return
Trans-Earth Cruise About 9 months
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Coming Home
S. Love, E. Nelson, Mars Mission Concept of Operations, Aug 2016  






ISS Testing Orion Proving Ground Mars
• Keep the crew safe
• Making sure they can get to Mars safely




All is well until the methods legitimated by the 
paradigm cannot cope with a cluster of anomalies; 
crisis results and persists until a new achievement 
redirects research and serves as a new paradigm.
- Thomas S. Kuhn 1962
What are the anomalies?
• NO real-time communications
– What does it mean to have a medically 
autonomous crew?
– Cannot provide real time guidance
– How do we train for medical needs?
– How do we keep skills fresh?
– What is the role of the flight surgeon?
– Do we transition from real time 
guidance to a store-and-forward 
consult model?
– What does it mean to provide situation 
awareness to earth-based support?
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More Anomalies
• NO regular resupply of materials
– How do we provide a safe and effective pharmacy when 
medications will expire?
– How do we plan to limit medical consumable usage 
when a crew is autonomous?
– How do we track that usage so the crew understands 
their risk posture throughout a mission?
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Does ISS prepare us?
• NO potential for evacuation if serious medical 
concerns arise.
– How do we plan for serious illness and injury?
– How long do we treat severe injury or illness?
– How do we decide what consumables to expend on an 
injured crew member such that we don’t increase the risk to 
the rest of the crew?
– How do we make ethical decisions in our plans for supplying 
a crew and recommendations to an autonomous crew on 





• From Conclusion 2: 
• “Currently, there is no 
comprehensive and inclusive 
strategy to provide optimum 
health care for astronauts in 
support of long-duration 
missions beyond low Earth 
orbit, nor is there sufficient 
coordination of health care 
needs with the engineering 
aspects of such missions.” 
• From Conclusion 6: 
• “The human being must be 
integrated into the space 
mission in the same way in 
which all other aspects of the 
mission are integrated.” 
Committee on Creating a Vision for Space Medicine During Travel Beyond Earth 
Orbit, Board on Health Sciences Policy and I. O. Medicine, Safe Passage: 
Astronaut Care for Exploration Missions, Institute of Medicine of the National 
Academies Press, 2001. 
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The Medical Engineering Challenge
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MEDICINE ENGINEERING
What is needed? What is possible?
SYSTEM
What you end up with.
Research
How can you get more of what is needed?
Fundamental Content Drivers
• Concept of Operations – The user’s experience of the system?
• Risk Assessment and Trade Capability – How do we value and prioritize 
medical capabilities?
• System Design
– Medical Data Architecture
– Medical Appliances
– Vehicle Integration
• Programmatics – What drives successful execution?




• Private Medical 
Conferences
• Self exams














• Private Medical 
Conferences
• Self exams









– CMO Directed Care
– Emergency Care
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What is needed Getting to Possible






• Characterize the likely 
medical risks
• Identify medical needs to 
address those risks
• Create a medical system to 
optimize crew response to 
those risks
• Engage in a testing pathway 
to validate and improve that 
system
• Work with vehicle engineers 
and flight surgeons to ensure  





































Atrial Fibrillation / Atrial Flutter


























































































k ~100 Medical Events
Medical Conditions for which we have not planned.
Spaceflight Medical Risk
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Three tools are highlighted which currently describe the medical 
trade space:
1. The Exploration Medical Condition List (EMCL)  - Identifies 
~100 conditions of interest for medical system development
2. The Integrated Medical Model (IMM)









Type of Medical 
Events




Mission Specific Inputs Quantified Outputs










Draft Data – Internal ExMC use only
Uses data from: IMM RunD-20150730-327RevA
Pre-decisional
Most useful medication 
categories for Mars DRM
Quantitative Risk - MONSTR
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Relative Importance of Labs 
for Mars DRM
Draft Data – Internal ExMC use only
Uses data from: IMM RunD-20150730-327RevA
Pre-decisional
What does it take to scope a medical system?
• How do we envision doing medicine?
– Planned medical operations
– Unplanned medical operations
– Performance
– Research 
• How do we value and prioritize medical capability?
– What is likely to happen and how often?
– What would a physician want to have with them if it happened?
– A repeatable way of prioritizing medical capability to invest research $$ in.
• How do we enable system operations that support crew 
autonomy?
– Information handling from lots of sources
– Command and control of devices (ultrasound, lab analysis, etc.)




SCOPING A MEDICAL SYSTEM
A medical system is judged by its ability to provide a crew fit for 
duty when called 
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Medical System Augments Crew Autonomy
Vehicle Exploration Medical System
• Crew Medical Officer
• Crew Medical Support
Real-Time Data Processing for Crew
• Flight Surgeon/BME
• External Consults





















































Medical System Capture Diagram
Programmatics and Ethics
2025 2030s
• Must have a target to design towards
• Must have a way to make hard decisions

















Med01 We do not have a concept of operations for medical care during exploration missions. 
Med02 We do not have the capability to provide a safe and effective pharmacy for exploration missions. 
Med03 We do not know how we are going to apply personalized medicine to reduce health risk for a selected crew. 
Med04
We do not have a defined rehabilitation capability for injured or de-conditioned crew members during exploration 
missions.
Med05
We do not know how to train crew for medical decision making or to perform diagnostic and therapeutic medical 
procedures to enable extended mission or autonomous operations. 
Med06
We do not know how to define medical planning or operational needs for ethical issues that may arise during 
exploration missions.
Med07
We do not have the capability to comprehensively process medically-relevant information to support medical 
operations during exploration missions. 
Med08 We do not have quantified knowledge bases and modeling to estimate medical risk incurred on exploration missions. 
Med09
We do not have the capability to predict estimated medical risk posture during exploration missions based on current 
crew health and resources. 
Med10 We do not have the capability to provide computed medical decision support during exploration missions. 
Med11 We do not have the capability to minimize medical system resource utilization during exploration missions.
Med12 We do not have the capability to mitigate select medical conditions 
Med13




• ExMC Research Pathway Changed 2015
• IMM external review finishing
• MONSTR phase 2 completed for evaluation
• Concept of Operations started, delivery of Mars transit ConOps expected 
February
• Pharmacy research plan expected in November
• Medical Data Architecture underway
• Medical Device Projects Continue
• Clinician’s Working Group created
• Systems Engineering and Operations Group created
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ExMC Data Architecture (ARC)

















































































































Metadata & Data Standards
Data Virtualization





Ground Data Architecture and IMPALA
• CHS already investing
• Creating a governance model
• Data Reservoir
• Analytics Platform





• FUS – Flexible Ultrasound
– Kidney stone diagnostics and therapies
– Bone healing
• RTA – Measure the degradation of pharmaceuticals non-invasively
• Dose Tracker – Track pharmaceutical usage, efficacy, and side 
effects
• Medical Consumables Tracker – RFID tagging to track 
pharmaceuticals usage
• EKG Cardiax device delivered to Space Station








































• MDA System 
Definition





• MDA System 
Enhancements





• Multi-agent Data Mining
• Computed Problem 
Solving
• Semantic Relations 
Network
• Optimized UI
• Ground System Int.
• Computed Clinical 
Diagnosis
• Augmented Intelligence
• Remote Data Asset 
Synchronization
• FDIR










• BHP appliances, 
apps and data
• HHC appliance apps 
and data
• Ground System Data 
Analytics Platform
• Vehicle Resources 
Oxygen, Medical 
Suction












Independent Evaluation of System































– Planning: Concept of Operations Development
– Characterization of Risk
– Active Risk Reduction (system to support 
crews)
– Engineering Testing Pathway































In 2001 Safe Passage: Astronaut Care for Exploration Missions prompted 
National Aeronautics and Space Administration (NASA) to improve the 
integration of the vehicle and human systems through a very intentional and 
evidence based design of medical systems to support human spaceflight for 
exploration missions
The Human Research Program was established in 2005 to focus NASA’s 
research on the highest risks to human health and performance during 
exploration missions. 
– Perform research necessary to understand and reduce spaceflight human health 
and performance risks in support of exploration
– Develop technologies to reduce medical risks
– Develop NASA spaceflight human system standards 
Providing health care capabilities for exploration class missions will 
necessitate the definition of new medical requirements and development of 
technologies to ensure the safety and success of exploration missions.
A Medical System should maximize flexibility to enable a care provider to 
address conditions that were not considered in the initial design.
Background
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• Current architectures for exploration call for 
long duration missions of 1-3 years 
• Mars will not have a capability for medical 
evacuation. 
• Mars missions cannot expect resupply 
although some prepositioning of resources 
may be available.
• There will be periods of limited 
communications and extended transit times.
– Comm rates: kilobits per second, like dial-up internet.
– The one-way flight time for radio signals can be more than 20 
minutes.
– Comm will not be continuous. 
• Mars Mission will require multiple launches
– Launch one or more durable unpiloted ships with non-
perishable supplies and equipment to Mars 78 or 52 or 26 
months before the crew departs.  
– Construct the crew transit ship in high Earth or Moon orbit 
with several SLS payloads launched 
– Crew launch. 
With low margins available on these missions, 
we can expect increasing scrutiny and 









































2013 Mortality Multiple Cause Micro-data Files
http://www.cdc.gov/nchs/data_access/Vitalstatsonline.htm
• Understanding Long 
Term Health effects 
is challenging
• Occupational 
Surveillance to follow 
lifetime challenges
• Human Research 
Program to identify 
emerging issues
Astronaut Long Term Health
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Concept of Operations
The ConOps captures the planned operational use of the exploration 
medical system. 
• Provides guidance on medical capabilities required for prevention, 
diagnosis, treatment, and rehabilitation as envisioned for a Mars Mission to 
enable crew medical autonomy. 
• Individuals will need to be sufficiently trained as medical officers
• The exploration medical system must be operable at the skill level of those 
selected to serve as medical officers.
• ConOps envisions and documents both planned and unplanned medical 




















For known risks: 
How do we decrease this?
Keep it from happening?








Mission Duration and 
Profile
Crew Composition
Type and Quantity of all 
Medical Events





System within Vehicle 
Constraints
Mission Specific Inputs Monte Carlo Simulations Quantified Outputs Informed Analysis
IMM Relational Database
Diagnosis and Treatment of Medical 
Conditions
Risks due to EVAs
ISS Medical System Resources
Medical Condition Incidence Data
13,500+ data 
elements





• Risk Mitigation Strategy
– Planning
• Concept of Operations Development (Ops Risk Reduction)
• Long Term Health Planning
– Characterization of Risk
• Models – Integrated Medical Model (IMM), MONSTR prototype
• Active Data Gathering – Medical Consumables Tracker (MCT), Biosensors, Flexible 
Ultrasound
• Medical Support – Exploration Medical System Demonstrator, Data Architecture
• Long Term Health data collection
– Active Risk Reduction
• Technology Development – Oxygen Concentrator Module, Medical Suction, IVGen…
• Training
• Decision Support
• Long Term Health interventions





























Plan, Analyze & 
Design





































• Awarded to Lockheed Martin
• Delivery date Sep 30, 2016
• Planned delivery date – Dec 2016 • Platform Sustainment and O&M
Phase 1a Phase 1b Phase 1c
Condition Use Case Resource Type Resource Criticality
Vital Signs 3
Physical Exam - Abdominal 3
Physical Exam - Trauma Survey 2
Ultrasound - AC 2







IV Access - Minor 2
IV Fluids 1
Monitoring - Standard 2
Medication Analgesics 3
IV Access - Minor 3
IV Access - Major 3
IV Fluids 2
Blood Products 3
Monitoring - ICU 3
Advanced Airway 3
Palliative Care 1
Surgery Surgery - Trauma 3
Antibiotics 1
Analgesics 3
Antifibrinolytics 2
Abdominal 
Injury
Diagnosis
Treatment 
(Best Case)
Treatment 
(Worst Case)
Procedure
Imaging
Lab
Procedure
Lab
Medication
